Regeneron

New Business

Patent cliffhanger: will China biotech throw Big Pharma a lifeline?

If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of…

Read More »
New Business

China’s biotech industry is gaining on the US. Can tariffs hold them back?

In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden…

Read More »
New Business

China vows stronger biotech support as deals with global pharmaceutical giants surge

Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster…

Read More »
Back to top button